Predicate Research Report · generated 2026-08-22 · Print / save as PDF · Save to account
Advocacy International, Ltd. · Predicate Candidate Screening
13 FDA 510(k) clearances under this manufacturer; the 50 most recent screened below.
58 daysmedian FDA review time
124 days90th percentile
13clearances measured
| K-number | Device | Applicant | Decided | Review days | Recalls (K-match) |
|---|---|---|---|---|---|
| K874027 | LIPASE UV [TOYO] | Advocacy International, Ltd. | 1988-05-27 | 238 | 0 |
| K873792 | SEPACELL R-500 AND SEPACELL R-500A | Advocacy International, Ltd. | 1988-01-19 | 124 | 0 |
| K855251 | MODIFICATION ASAHI NEW PAN-SERIES HEMOFILTERS | Advocacy International, Ltd. | 1986-02-04 | 36 | 0 |
| K855212 | ASAHI AM SERIES DIALYZERS | Advocacy International, Ltd. | 1986-01-21 | 22 | 0 |
| K854259 | SEPACELL R-500 & SEPACELL R-500A | Advocacy International, Ltd. | 1986-01-08 | 77 | 0 |
| K842103 | TOYO JOZO URIC ACID TEST | Advocacy International, Ltd. | 1984-08-12 | 79 | 0 |
| K842104 | TOYO JOZO G-GTP TEST | Advocacy International, Ltd. | 1984-08-10 | 77 | 0 |
| K830231 | ASAHI HOLLOW FIBER KIDNEYS, AM-SERIES | Advocacy International, Ltd. | 1983-03-17 | 58 | 0 |
| K830183 | ASAHI HOLLOW FIBER KIDNEYS NR SERIES | Advocacy International, Ltd. | 1983-03-17 | 58 | 0 |
| K823733 | EIKEN KIZAI ARTIFICIAL KIDNEY BLOOD CIR | Advocacy International, Ltd. | 1983-01-14 | 32 | 0 |
| K813037 | FLOWGUARD CATHETERS & CANNALAE | Advocacy International, Ltd. | 1981-12-14 | 47 | 0 |
| K813035 | POLYSTAN VERTICLUDE BLOOD PUMP | Advocacy International, Ltd. | 1981-11-27 | 30 | 0 |
| K813034 | POLYSTAN HEART LUNG MACHINE SYS | Advocacy International, Ltd. | 1981-11-27 | 30 | 0 |
Methodology
Recall counts reflect FDA recall records explicitly referencing each K-number; FDA links recalls to K-numbers inconsistently, so 0 means "none found in FDA records," not "never recalled." Data: FDA openFDA, refreshed weekly. Verify decisions of consequence against the primary source. Full candidate set and CSV export: atlasbyauro.com.
Prepared with Atlas
Predicate research, review-time statistics and recall monitoring for 510(k) teams: atlasbyauro.com/fda